YASUHIRO contact IKEDA

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. pmc Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells
    Seiga Ohmine
    Department of Molecular Medicine, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Stem Cell Res Ther 2:46. 2011
  2. pmc Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation
    Tayaramma Thatava
    Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Stem Cell Res Ther 2:48. 2011
  3. pmc No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan
    Rika A Furuta
    Department of Research, Japanese Red Cross Osaka Blood Center, 2 4 43 Morinomiya, Joto ku, Osaka 536 8505, Japan
    Retrovirology 8:20. 2011
  4. pmc No evidence of XMRV in prostate cancer cohorts in the Midwestern United States
    Toshie Sakuma
    Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Retrovirology 8:23. 2011
  5. pmc Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats
    Alessandro Cataliotti
    Molecular Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Circulation 123:1297-305. 2011
  6. pmc Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahari
    Toshie Sakuma
    Department of Molecular Medicine, Mayo Clinic, Guggenheim 18 11c, 200 First Street, SW, Rochester, MN 55905, USA
    J Virol 85:1205-13. 2011

Research Grants

Collaborators

  • Fernando L Martin
  • Greg J Towers
  • Toshie Sakuma
  • Tayaramma Thatava
  • Seiga Ohmine
  • Jason M Tonne
  • Yogish C Kudva
  • Karen A Squillace
  • Rika A Furuta
  • Alessandro Cataliotti
  • Yulia Krotova Khan
  • Kah Whye Peng
  • Eiji Sato
  • Stephen J Russell
  • Takayuki Miyazawa
  • John C Burnett
  • Jamie L Sundsbak
  • Takeki Sugiyama
  • Allan B Dietz
  • Michael A Barry
  • Jarryd M Campbell
  • Yasuhito Nakatomi
  • Naoko Misawa
  • Diego Bellavia
  • Josep Genebriera De Lamo
  • David R Miller
  • Ramakrishna Edukulla
  • Michael C Deeds
  • Katherine A Hartjes
  • Hirohiko Kuratsune
  • Ryuta Sakuma
  • Lorenzo S Malatino
  • Stephane Hue
  • Elise A Oehler
  • Gerald E Harders
  • Adam S Armstrong
  • Kazuta Yasui
  • Patrick R Blackburn
  • Fumiya Hirayama
  • Kaw Whye Peng
  • Kouzi Yamaguti
  • Peter C Harris

Detail Information

Publications6

  1. pmc Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells
    Seiga Ohmine
    Department of Molecular Medicine, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Stem Cell Res Ther 2:46. 2011
    ..One of the key issues for clinical-grade iPSC derivation is the accessibility of donor cells used for reprogramming...
  2. pmc Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation
    Tayaramma Thatava
    Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Stem Cell Res Ther 2:48. 2011
    ..Induced pluripotent stem (iPS) cell technology, which allows derivation of patient-specific pluripotent stem cells, could provide a possible alternative modality for kidney replacement therapy for patients with ESRD...
  3. pmc No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan
    Rika A Furuta
    Department of Research, Japanese Red Cross Osaka Blood Center, 2 4 43 Morinomiya, Joto ku, Osaka 536 8505, Japan
    Retrovirology 8:20. 2011
    ..We also examined blood samples of viral antibody-positive patients with PC and all (both antibody-positive and antibody-negative) patients with CFS for XMRV DNA...
  4. pmc No evidence of XMRV in prostate cancer cohorts in the Midwestern United States
    Toshie Sakuma
    Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Retrovirology 8:23. 2011
    ..To address the association between XMRV infection and PCa, we have tested prostate tissues and human sera for the presence of viral DNA, viral antigens and anti-XMRV antibodies...
  5. pmc Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats
    Alessandro Cataliotti
    Molecular Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Circulation 123:1297-305. 2011
    ..In the current study, we tested the effects of sustained cardiac proBNP gene delivery on BP, cardiac function, and remodeling in spontaneously hypertensive rats (SHR)...
  6. pmc Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahari
    Toshie Sakuma
    Department of Molecular Medicine, Mayo Clinic, Guggenheim 18 11c, 200 First Street, SW, Rochester, MN 55905, USA
    J Virol 85:1205-13. 2011
    ..These data support the use of Mus pahari as a model for XMRV pathogenesis and as a platform for vaccine and drug development against this potential human pathogen...

Research Grants2

  1. Regulated Long-Term Cardiac BNP Expression in Hypertensive Heart Disease
    YASUHIRO contact IKEDA; Fiscal Year: 2010
    ..We will test if regulated long-term cardiac BNP expression ameliorates HHD. Our results will elucidate the role of BNP in hypertension and may lead to a novel chronic BNP therapy strategy for human HHD. ..